Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2012-04-20

European Medicines Agency recommends authorisation of novel treatment for type-2 diabetes

View source ↗

Summary

The European Medicines Agency recommends authorisation of a novel treatment for type 2 diabetes, signaling potential new option for management of the disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications